- Home
- THCH vs NOTV Comparison
THCH vs NOTV Comparison
Compare THCH & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THCH
- NOTV
- Stock Information
- Founded
- THCH 2018
- NOTV 1974
- Country
- THCH China
- NOTV United States
- Employees
- THCH N/A
- NOTV N/A
- Industry
- THCH Blank Checks
- NOTV Biotechnology: Pharmaceutical Preparations
- Sector
- THCH Finance
- NOTV Health Care
- Exchange
- THCH Nasdaq
- NOTV Nasdaq
- Market Cap
- THCH 84.8M
- NOTV 72.1M
- IPO Year
- THCH N/A
- NOTV 1997
- Fundamental
- Price
- THCH $2.60
- NOTV $1.89
- Analyst Decision
- THCH
- NOTV Strong Buy
- Analyst Count
- THCH 0
- NOTV 1
- Target Price
- THCH N/A
- NOTV $5.00
- AVG Volume (30 Days)
- THCH 11.8K
- NOTV 501.3K
- Earning Date
- THCH 08-28-2025
- NOTV 08-06-2025
- Dividend Yield
- THCH N/A
- NOTV N/A
- EPS Growth
- THCH N/A
- NOTV N/A
- EPS
- THCH N/A
- NOTV N/A
- Revenue
- THCH $187,384,526.00
- NOTV $505,299,000.00
- Revenue This Year
- THCH N/A
- NOTV $4.99
- Revenue Next Year
- THCH N/A
- NOTV $5.39
- P/E Ratio
- THCH N/A
- NOTV N/A
- Revenue Growth
- THCH N/A
- NOTV 0.85
- 52 Week Low
- THCH $1.95
- NOTV $1.15
- 52 Week High
- THCH $5.15
- NOTV $6.48
- Technical
- Relative Strength Index (RSI)
- THCH 40.71
- NOTV 45.54
- Support Level
- THCH $2.49
- NOTV $1.79
- Resistance Level
- THCH $2.90
- NOTV $2.13
- Average True Range (ATR)
- THCH 0.26
- NOTV 0.19
- MACD
- THCH -0.02
- NOTV -0.01
- Stochastic Oscillator
- THCH 65.66
- NOTV 20.00
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.